Fighting malaria during the COVID-19 pandemic: an interview with David Reddy, CEO of MMV

17 Aug 2021

The COVID-19 pandemic has disturbed many aspects of our lives. Entire societies and their health systems have struggled to adapt. Medicines for Malaria Venture works to prevent and cure malaria in endemic countries. This past year the organization has had to address the threat of two deadly diseases: malaria and COVID-19. The CEO, David Reddy takes us behind the scenes to share his lessons learnt and the challenges that still lie ahead.